BioAtla (BCAB) Earnings Analysis
BioAtla (BCAB) next reports earnings on 2026-08-06, consensus EPS -8.5 USD. Last quarter (2026-05-15) it beat with EPS -6.18 USD vs -10 USD est (+38.2%). It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E -0.08.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BCAB next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -8.5 USD |
| Revenue estimate | n/a |
BCAB earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-15 | -6.18 USD | -10 USD | +38.2% | Beat |
| 2026-03-31 | -8 USD | -12 USD | +33.3% | Beat |
| 2025-11-13 | -0.27 USD | -0.31 USD | +12.9% | Beat |
Beat rate: 3/3 (100%) over reported quarters with consensus data.
BCAB valuation and analyst view
| Trailing P/E | -0.08 |
|---|---|
| Trailing EPS | -33.70761 USD |
| Price / book | -0.14 |
| Dividend yield | 0.00% |
| Market cap | 0.00B |
| Analyst consensus | Buy (6 buy / 3 hold / 0 sell) |
Related research pages
Frequently asked questions
When is BioAtla (BCAB)'s next earnings date?
BioAtla is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -8.5 USD.
Did BCAB beat earnings last quarter?
In its 2026-05-15 report, BCAB posted EPS of -6.18 USD versus a -10 USD estimate — a beat of 38.2%.
What is BCAB's earnings track record?
Over the last 3 reported quarters with consensus data, BCAB beat estimates 3 times (100%).
What is BCAB's current P/E ratio and EPS?
BCAB trades at a trailing P/E of -0.08 on trailing EPS of -33.70761076656396 USD.
What do analysts rate BCAB?
Analyst consensus is "Buy" across 9 ratings (0 strong buy, 6 buy, 3 hold, 0 sell, 0 strong sell).